- Home
- THAR vs BFRG Comparison
THAR vs BFRG Comparison
Compare THAR & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- BFRG
- Stock Information
- Founded
- THAR 2017
- BFRG 2017
- Country
- THAR United States
- BFRG United States
- Employees
- THAR N/A
- BFRG N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- BFRG Retail: Computer Software & Peripheral Equipment
- Sector
- THAR Health Care
- BFRG Technology
- Exchange
- THAR Nasdaq
- BFRG Nasdaq
- Market Cap
- THAR 16.8M
- BFRG 15.4M
- IPO Year
- THAR 2022
- BFRG 2023
- Fundamental
- Price
- THAR $3.16
- BFRG $1.53
- Analyst Decision
- THAR Strong Buy
- BFRG
- Analyst Count
- THAR 1
- BFRG 0
- Target Price
- THAR $17.00
- BFRG N/A
- AVG Volume (30 Days)
- THAR 556.4K
- BFRG 443.4K
- Earning Date
- THAR 11-06-2025
- BFRG 11-07-2025
- Dividend Yield
- THAR N/A
- BFRG N/A
- EPS Growth
- THAR N/A
- BFRG N/A
- EPS
- THAR N/A
- BFRG N/A
- Revenue
- THAR N/A
- BFRG $33,257.00
- Revenue This Year
- THAR N/A
- BFRG N/A
- Revenue Next Year
- THAR N/A
- BFRG N/A
- P/E Ratio
- THAR N/A
- BFRG N/A
- Revenue Growth
- THAR N/A
- BFRG N/A
- 52 Week Low
- THAR $0.95
- BFRG $1.09
- 52 Week High
- THAR $9.08
- BFRG $4.84
- Technical
- Relative Strength Index (RSI)
- THAR 51.38
- BFRG 57.22
- Support Level
- THAR $2.79
- BFRG $1.28
- Resistance Level
- THAR $3.52
- BFRG $2.04
- Average True Range (ATR)
- THAR 0.25
- BFRG 0.15
- MACD
- THAR 0.02
- BFRG 0.00
- Stochastic Oscillator
- THAR 51.02
- BFRG 31.57
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.